Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Antibiotic Selection00:57

Antibiotic Selection

59.3K
Overview
59.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

1.2K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.2K
Phase II Conjugation Reactions: Overview01:14

Phase II Conjugation Reactions: Overview

732
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
732

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunogenicity and safety of a pentavalent meningococcal MenABCWY vaccine in healthy adolescents and young adults: a phase 3, multicountry, randomised, observer-blinded, active-controlled non-inferiority trial.

The Lancet. Child & adolescent health·2026
Same author

Epigenetic regulation of fruit shape determination by the JAGGED gene in Capsella rubella.

Nature communications·2026
Same author

Cefepime/enmetazobactam steady-state concentrations in spondylodiscitis-relevant tissues: an experimental porcine study.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2026
Same author

[Prosthetic infections in the aorta and iliac vessels].

Ugeskrift for laeger·2026
Same author

Limits of bacterial osmoadaptation during planktonic and biofilm growth: a step toward effective biofouling control.

Applied and environmental microbiology·2026
Same author

Investigating the Impact of Host Genetics on the Risk of Disease Progression in Individuals With Influenza.

Immunity, inflammation and disease·2026

Related Experiment Video

Updated: Jan 9, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.6K

Broad-Spectrum Antimicrobial Treatment Targeted Through Drug Conjugation to Vancomycin.

Magnus Schou Dybtved1, Maiken E Petersen2, Alif Firman Firdausy2

  • 1Department of Chemistry, Aarhus University, Aarhus, Denmark.

Advanced Healthcare Materials
|December 9, 2025
PubMed
Summary

We developed a targeted antimicrobial drug conjugate to combat resistant bacteria, persister cells, and biofilms. This novel approach shows potent in vitro activity and good in vivo tolerance, though further optimization is needed for clinical efficacy.

Keywords:
antibioticsbroad spectrum antimicrobialdrug conjugationdrug targetingmitomycinvancomycin

More Related Videos

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.7K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.3K

Related Experiment Videos

Last Updated: Jan 9, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.6K
A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.7K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.3K

Area of Science:

  • Microbiology
  • Drug Discovery
  • Bioconjugation

Background:

  • Antimicrobial resistance, microbial persister cells, and biofilms pose significant global health challenges.
  • Current treatments often lack specificity and efficacy against these persistent microbial threats.

Purpose of the Study:

  • To develop a targeted delivery system for antimicrobial compounds to overcome resistance and enhance efficacy.
  • To create a novel conjugate combining mitomycin C with vancomycin for broad-spectrum antibacterial activity.

Main Methods:

  • Conjugation of mitomycin C to vancomycin via a disulfide linker, optimizing drug attachment site.
  • In vitro testing against Gram-positive and Gram-negative bacteria, including vancomycin-resistant strains and biofilms.
  • In vivo evaluation in a mouse model of implant-associated osteomyelitis.

Main Results:

  • The lead conjugate demonstrated broad-spectrum antibacterial activity in vitro, including against resistant strains and biofilms.
  • Targeted treatment showed significantly enhanced potency and reduced cytotoxicity compared to free mitomycin C.
  • In vivo studies confirmed robust targeting and good tolerance in a mouse osteomyelitis model.

Conclusions:

  • The developed vancomycin-mitomycin C conjugate is a promising strategy for targeted antimicrobial therapy.
  • While demonstrating potent in vitro and in vivo characteristics, further research is required to optimize therapeutic efficacy for specific disease models.